Sanofi to cut US price of its most-prescribed insulin by 78%

Sanofi cuts insulin cost to $35, third major drug company to do so

Sanofi cuts U.S. list price of Lantus®, its most-prescribed

Bottom Line, not Altruism, Could be the Main Driver of Lilly's

Sanofi is third major insulin maker to cut prices - SmartBrief

Third drugmaker cuts insulin prices

Sanofi cuts price of Lantus, most prescribed insulin in US

insulin Archives

Sanofi cuts price of insulin Lantus, following Eli Lilly, Novo Nordisk

Sanofi becomes latest drugmaker to announce insulin price cuts

Eli Lilly caps insulin out-of-pocket costs at $35 per month

Lantus - sales performance, data and rankings - Top Pharma List